Explore our materials

Filters

Results (4448)

HIV DART and Emerging Viruses 2018

HIV reservoir dynamics: Implications for HIV latency establishment and reversal | Deanna Kulpa, PhD

HIV DART and Emerging Viruses 2018

State of the Art Lecture: Molecular basis for HIV latency | Jonathan Karn, PhD

HIV DART and Emerging Viruses 2018

Understanding barriers to HIV cure | Robert Siliciano, MD, PhD

HIV DART and Emerging Viruses 2018

Baricitinib reverses HIV associated neurocognitive disorders and reservoir seeding in a SCID mouse model | Christina Gavegnano, PhD

Steven Deeks

MD

HIV DART and Emerging Viruses 2018

State of the Art Lecture: Harnessing the immune system to eliminate and/or control HIV | Steven Deeks, MD

Bonaventura Clotet

MD, PhD

HIV DART and Emerging Viruses 2018

Barry-Wainberg DART Achievement Award Lecture: Overview of the research conducted at the Irsicaixa Foundation | Bonaventura Clotet, MD, PhD

International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2018

Targeted agents and monoclonal antibodies | Joseph Ciccolini, PharmD, PhD

International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2018

Cytotoxic agents | Markus Jörger, MD, PhD

Howard Gurney

MBBS, FRACP

International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2018

Rationale for selecting combinations with immunotherapy | Howard Gurney, MBBS, FRACP

International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2018

Immunotherapy of prostate cancer and urothelial cancer. Future directions | Winald Gerritsen

International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2018

Drug-drug interaction management with DDI-Predictor | Michel Tod, PharmD, PhD

International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2018

Pharmacotherapy of Comorbities: Cancer Patients with HIV/AIDS | Michelle Rudek, PharmD, PhD